Breath Actuated Nebulizer Improves Quality of Care in Pediatric Emergency Department Asthma and Leads to System Wide Implementaion

PAS Conference, Baltimore, Maryland 2009
MUSC Children's Hospital, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
C. J. H. Bong
M. Eady
C. M. Bowman
M. O. Titus








Purpose of Study:

BACKGROUND:

  • Breath actuated nebulizers have improved asthma care in adults.
  • Children's Hospital and ResearchCenter at Oakland- reduced clinical asthma scores (CAS), hospitalization rates, and respiratory rates with AeroEclipse II Breath Actuated Nebulizer (BAN).

 

OBJECTIVE:

  • To determine if albuterol (ALB) delivery via BAN vs. conventional continuous nebulizer optimizes care and reduces cost in pediatric patients treated for wheeze/asthma in the MUSC Pediatric Emergency Department (PED).

 

CONCLUSIONS:

 

  •  Shorter PED LOS & shorter treatment times

- BAN treated patients spent ~1/3 less time in PED (53 min shorter LOS)

- Decreases wait time for PED care with more rapid room turn over

  • Improved delivery, less waste

            -Decreased ambient loss of medication: BAN ~4% vs. ~30% with CNB

            -Reusable device can be used for up to 1 week in hospital or home

            -Moderate group used 47% less albuterol per treatment compared to CNB group